AUTHOR=Boldrini Luca , Bibault Jean-Emmanuel , Masciocchi Carlotta , Shen Yanting , Bittner Martin-Immanuel 

TITLE=Deep Learning: A Review for the Radiation Oncologist

JOURNAL=Frontiers in Oncology

VOLUME=9

YEAR=2019

URL=https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2019.00977

DOI=10.3389/fonc.2019.00977

ISSN=2234-943X

ABSTRACT=<p><bold>Introduction:</bold> Deep Learning (DL) is a machine learning technique that uses deep neural networks to create a model. The application areas of deep learning in radiation oncology include image segmentation and detection, image phenotyping, and radiomic signature discovery, clinical outcome prediction, image dose quantification, dose-response modeling, radiation adaptation, and image generation. In this review, we explain the methods used in DL and perform a literature review using the Medline database to identify studies using deep learning in radiation oncology. The search was conducted in April 2018, and identified studies published between 1997 and 2018, strongly skewed toward 2015 and later.</p><p><bold>Methods:</bold> A literature review was performed using PubMed/Medline in order to identify important recent publications to be synthesized into a review of the current status of Deep Learning in radiation oncology, directed at a clinically-oriented reader. The search strategy included the search terms “radiotherapy” and “deep learning.” In addition, reference lists of selected articles were hand searched for further potential hits of relevance to this review. The search was conducted in April 2018, and identified studies published between 1997 and 2018, strongly skewed toward 2015 and later.</p><p><bold>Results:</bold> Studies using DL for image segmentation were identified in Brain (<italic>n</italic> = 2), Head and Neck (<italic>n</italic> = 3), Lung (<italic>n</italic> = 6), Abdominal (<italic>n</italic> = 2), and Pelvic (<italic>n</italic> = 6) cancers. Use of Deep Learning has also been reported for outcome prediction, such as toxicity modeling (<italic>n</italic> = 3), treatment response and survival (<italic>n</italic> = 2), or treatment planning (<italic>n</italic> = 5).</p><p><bold>Conclusion:</bold> Over the past few years, there has been a significant number of studies assessing the performance of DL techniques in radiation oncology. They demonstrate how DL-based systems can aid clinicians in their daily work, be it by reducing the time required for or the variability in segmentation, or by helping to predict treatment outcomes and toxicities. It still remains to be seen when these techniques will be employed in routine clinical practice.</p>